Statizoid

Botswana vs Rwanda: Statin use vs. average non-HDL cholesterol levels

Botswana
2.7
in 2018
Rwanda
2.6
in 2018
Botswana rank
184th
Rwanda rank
187th

Statin use vs. average non-HDL cholesterol levels over time

  • Botswana
  • Rwanda
0123198019992018

How they compare

Botswana currently reports 2.7 against 2.6 in Rwanda, a difference of 0.1.

Across all 39 years both countries report, Botswana has been ahead every year.

Botswana ranks 184th and Rwanda ranks 187th of 191 countries.

Individual pages

About this data

Indicator
Statin use vs. average non-HDL cholesterol levels
Source
World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
191 places, 7,449 data points, 1980–2018
Last refreshed

The use of statins in the population. This is compared to average non-HDL cholesterol levels, in mmol/L. Statins are a type of drug that reduce non-HDL cholesterol levels, and are used to treat and prevent cardiovascular diseases in people at heightened risk. Their usage is measured in Defined Daily Doses, per 1,000 people.